Neurodegeneration in an Aβ‐induced model of Alzheimer’s disease: the role of Cdk5
The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Summary: Cdk5 dysregulation is a major event in the neurodegenerative process of Alzheimer’s disease (AD). In vitro studies using differentiated neurons exposed to Aβ exhibit Cdk5‐mediated tau hyperphosphorylation, cell cycle re‐entry and neuronal loss. In this study we aimed to determine the role of Cdk5 in neuronal injury occurring in an AD mouse model obtained through the intracerebroventricular (icv) injection of the Aβ 1–40 synthetic peptide. In mice icv‐injected with Aβ, Cdk5 activator p35 is cleaved by calpains, leading to p25 formation and Cdk5 overactivation. Subsequently, there was an increase in tau hyperphosphorylation, as well as decreased levels of synaptic markers. Cell cycle reactivation and a significant neuronal loss were also observed. These neurotoxic events in Aβ‐injected mice were prevented by blocking calpain activation with MDL28170, which was administered intraperitoneally (ip). As MDL prevents p35 cleavage and subsequent Cdk5 overactivation, it is likely that this kinase is involved in tau hyperphosphorylation, cell cycle re‐entry, synaptic loss and neuronal death triggered by Aβ. Altogether, these data demonstrate that Cdk5 plays a pivotal role in tau phosphorylation, cell cycle induction, synaptotoxicity, and apoptotic death in postmitotic neurons exposed to Aβ peptides in vivo, acting as a link between diverse neurotoxic pathways of AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease
Arriagada, P. V., Growdon, J. H., Hedley-Whyte, E. T., & Hyman, B. T. (1992) · Neurology · doi:10.1212/wnl.42.3.631 · Cited by 2,668
Kitazawa, M., Oddo, S., Yamasaki, T. R., Green, K. N., & LaFerla, F. M. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2868-05.2005 · Cited by 697 · cited 1×
“Cdk5 overactivation has been demonstrated in neuronal cultures exposed to Ab and transgenic models of AD (Cruz et al., 2003; Kitazawa et al., 2005; Lopes et al., 2007).”
BackgroundCruz, J. C., Tseng, H.-C., Goldman, J. A., Shih, H., & Tsai, L.-H. (2003) · Neuron · doi:10.1016/s0896-6273(03)00627-5 · Cited by 609
Ectopic Cell Cycle Proteins Predict the Sites of Neuronal Cell Death in Alzheimer’s Disease Brain
Busser, J., Geldmacher, D. S., & Herrup, K. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-08-02801.1998 · Cited by 543 · cited 4×
“Cell cycle reactivation has been observed in the brain of AD patients (Busser et al., 1998), AD mouse models (Yang et al., 2006) as well as in cultured neurons exposed to Ab peptides (Biswas et al., 2007; Majd et al., 2008; Lopes et al., 2009a).”
BackgroundInfluentialThe pRb/E2F cell-cycle pathway mediates cell death in Parkinson's disease
Höglinger, G. U., Breunig, J. J., Depboylu, C., Rouaux, C., Michel, P. P., Alvarez-Fischer, D., Boutillier, A.-L., DeGregori, J., Oertel, W. H., Rakic, P., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611671104 · Cited by 276 · cited 4×
“, 2007), there was also the re-expression of different cell cycle markers (Nguyen et al., 2003; Kuan et al., 2004; Hernandez-Ortega et al., 2007; Hoglinger et al., 2007).”
BackgroundInfluentialEckermann, K., Mocanu, M.-M., Khlistunova, I., Biernat, J., Nissen, A., Hofmann, A., Schönig, K., Bujard, H., Haemisch, A., Mandelkow, E., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705282200 · Cited by 168 · cited 5×
“In AD, Cdk5 overactivation is associated with tau hyperphosphorylation, which culminates with the formation of neurofibrillary tangles (Hardy, 2003; Lee & Tsai, 2003) and can also be correlated to phenomena such as synaptic loss or neuronal death (Arriagada et al., 1992; Hamdane et al., 2003; Eckermann et al., 2007).”
BackgroundInfluentialCdk5 is involved in NFT-like tauopathy induced by transient cerebral ischemia in female rats
Wen, Y., Yang, S.-H., Liu, R., Perez, E. J., Brun-Zinkernagel, A. M., Koulen, P., & Simpkins, J. W. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.10.011 · Cited by 162
Nuclear localization of Cdk5 is a key determinant in the postmitotic state of neurons
Zhang, J., Cicero, S. A., Wang, L., Romito-DiGiacomo, R. R., Yang, Y., & Herrup, K. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711355105 · Cited by 113
The Relationship between Amyloid and Tau
Hardy, J. (2003) · Journal of Molecular Neuroscience · doi:10.1385/jmn:20:2:203 · Cited by 80
Majd, S., Zarifkar, A., Rastegar, K., & Takhshid, M. A. (2008) · Brain Research · doi:10.1016/j.brainres.2008.04.050 · Cited by 51 · cited 2×
“Cell cycle reactivation has been observed in the brain of AD patients (Busser et al., 1998), AD mouse models (Yang et al., 2006) as well as in cultured neurons exposed to Ab peptides (Biswas et al., 2007; Majd et al., 2008; Lopes et al., 2009a).”
Cited by
Post-translational modifications of tau protein: Implications for Alzheimer's disease
Martin, L., Latypova, X., & Terro, F. (2011) · Neurochemistry International · doi:10.1016/j.neuint.2010.12.023 · Cited by 641
Tau protein kinases: Involvement in Alzheimer's disease
Martin, L., Latypova, X., Wilson, C. M., Magnaudeix, A., Perrin, M.-L., Yardin, C., & Terro, F. (2013) · Ageing Research Reviews · doi:10.1016/j.arr.2012.06.003 · Cited by 631
The Role of Cdk5 in Alzheimer’s Disease
Liu, S.-L., Wang, C., Jiang, T., Tan, L., Xing, A., & Yu, J.-T. (2016) · Molecular Neurobiology · doi:10.1007/s12035-015-9369-x · Cited by 269
Park, J., Choi, H., Min, J., Kim, B., Lee, S., Yun, J. W., Choi, M., Chang, K., & Lee, D. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.12984 · Cited by 93
Wu, X., Yang, Z., Zou, J., Gao, H., Shao, Z., Li, C., & Lei, P. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02179-x · Cited by 88
Metadata
- Authors
- Lopes, J. P., Oliveira, C. R., & Agostinho, P.
- Venue
- Aging Cell
- Publisher
- Wiley
- Published
- 2010-01-11
- Volume
- 9
- Issue
- 1
- Pages
- 64-77
- ISSN
- 1474-9718 (ISSN-L)
- 1474-9726
- OpenAlex
- W2110317837
- Cited by
- 86
- References
- 11
- FWCI
- 5.31
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Neurodegeneration in an Aβ‐induced model of Alzheimer’s disease: the role of Cdk5. https://app.cochat.ai/papers/10.1111/j.1474-9726.2009.00536.x
- The paper
- Lopes, J. P., Oliveira, C. R., & Agostinho, P. (2010). Neurodegeneration in an Aβ‐induced model of Alzheimer’s disease: the role of Cdk5. Aging Cell. https://doi.org/10.1111/j.1474-9726.2009.00536.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.